Givaudan has reached an agreement to acquire certain cosmetic ingredients from biotech company Amyris, Inc., including Neossance Squalane, Neossance Hemisqualane and a suncare ingredient called CleanScreen.  Work inside the lab at Amyris. The companies signed a long-term partnership agreement under which Amyris will continue to manufacture ingredients for Givaudan to use in cosmetics, as well as provide access to its innovation capabilities. Further, Givaudan will become the commerc...